Why is Alembic Pharma falling/rising?

As of 30-Jun, Alembic Pharmaceuticals Ltd. is experiencing a significant rise in its stock price, currently at 1,042.60, reflecting an increase of 68.4 points or 7.02%. The stock has shown strong performance today, outperforming its sector by 6.33% and has been on a consecutive gain streak for the last five days, resulting in an overall return of 11.18% during this period. Additionally, the stock opened with a gain of 5.7% today and reached an intraday high of Rs 1107.8, indicating robust trading activity. Despite a slight decline in delivery volume, the stock's ability to trade above its moving averages suggests positive momentum. The company's strong debt servicing capability, as evidenced by a low Debt to EBITDA ratio of 0.67 times, and an attractive valuation compared to peers, further support the stock's upward movement.
In the broader market context, Alembic Pharmaceuticals has outperformed the benchmark Sensex, which has only seen a 2.09% increase over the past week. While the stock has generated a return of 18.96% over the last year, significantly higher than the market's 3.95%, it is important to note that the company's profits have declined by 7% during the same period. High institutional holdings at 20.37% indicate confidence from more sophisticated investors, which may contribute to the stock's positive trajectory. However, the stock's year-to-date performance shows a decline of 1.56%, suggesting that while recent movements are strong, there are underlying challenges that could affect future performance.